diltiazem has been researched along with Kidney Diseases in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (8.70) | 18.7374 |
| 1990's | 13 (56.52) | 18.2507 |
| 2000's | 6 (26.09) | 29.6817 |
| 2010's | 2 (8.70) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adeneye, AA; Akindele, AJ; Benebo, AS; Olatoye, F | 1 |
| Itokawa, H; Kato, A; Michio, F; Moriya, M; Nakashima, K; Noda, M; Ogura, Y; Oishi, A; Okamoto, N | 1 |
| Gaughan, JP; Khandelwal, M; Kumanova, M; Reece, EA | 1 |
| Chen, LQ; Chen, LZ; Chen, YH; Hu, JB; Li, WL; Liang, JJ; Liang, YX; Qiu, J; Xie, KJ; Zhang, J; Zheng, KL; Zhong, WD | 1 |
| Cervenka, L; Heller, J | 1 |
| Kudoh, S; Satoh, A | 1 |
| Ali, BH; Bashir, AA | 1 |
| Bernheim, J; Green, J; Haskiah, A; Podjarny, E; Pomeranz, A; Rathaus, M | 1 |
| Bianchi, C; Caputo, M; Donadio, C; Giordani, R; Lucchetti, A; Silvestri, L; Tramonti, G | 1 |
| Furukawa, H; Iwaki, K; Iwasaki, T; Kawakami, M; Matsumura, S; Matsunaga, K; Shimamura, T; Yonetani, Y | 1 |
| Adrogue, HJ; Goldstein, R; Hricik, DE; Levine, BS; Weinberg, MS | 1 |
| Balogh, A; Fleck, C; Kostka, E; Kühl, A; Kuhn, UD; Lupp, A; Stein, G | 1 |
| Chen, WC; Jan, CR; Tseng, CJ; Wu, SN | 1 |
| Ito, K; Suzuki, T; Tada, H; Yanagiwara, S | 1 |
| Amar, D; Fleisher, M | 1 |
| Chen, JC; Ma, P | 1 |
| Chen, KM; Jia, YF; Morcos, SK; Wang, YX | 1 |
| Antonijoan, RM; Barbanoj, MJ; Diaz, JM; Estorch, M; Gich, I; Guirado, LL; Paredes, D; Solà, R; Vila, LP | 1 |
| Freeman, D; Keown, P; McDonald, J; Petric, R; Stiller, C; Wallace, C | 1 |
| Epstein, M | 1 |
| Hartz, PA; Wilson, PD | 1 |
| McGoon, MD; Shub, C; Vlietstra, RE | 1 |
| Kuhlmann, J | 1 |
2 review(s) available for diltiazem and Kidney Diseases
| Article | Year |
|---|---|
Diltiazem and renal hemodynamics: implications for renal protection.
Topics: Animals; Diltiazem; Dogs; Hemodynamics; Humans; Kidney; Kidney Diseases; Rats; Renal Circulation | 1991 |
Selection of optimal drug therapy for the patient with angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 1; Diltiazem; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug Tolerance; Heart Rate; Heart Ventricles; Humans; Hypertension; Kidney Diseases; Lung Diseases; Myocardium; Nifedipine; Nitrates; Physical Exertion; Receptors, Adrenergic, beta; Systole; Vascular Diseases; Vasodilation; Verapamil | 1985 |
4 trial(s) available for diltiazem and Kidney Diseases
| Article | Year |
|---|---|
Renal effects of prolonged antihypertensive treatment with diltiazem.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Diltiazem; Enzymes; Female; Humans; Hypertension; Kidney; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Renal Circulation | 1996 |
Evaluation of enalapril/diltiazem ER in hypertensive patients with coexisting renal dysfunction. Enalapril/Diltiazem ER in Hypertensive Renal Disease Group.
Topics: Adult; Aged; Blood Pressure; Creatinine; Delayed-Action Preparations; Diltiazem; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Humans; Hypertension; Kidney Diseases; Male; Middle Aged; Proteinuria | 1996 |
Diltiazem treatment does not alter renal function after thoracic surgery.
Topics: Aged; Cardiovascular Agents; Diltiazem; Female; Humans; Kidney Diseases; Male; Pneumonectomy; Postoperative Complications; Prospective Studies | 2001 |
Effects of verapamil, diltiazem, and nifedipine on plasma levels and renal excretion of digitoxin.
Topics: Aged; Benzazepines; Clinical Trials as Topic; Digitoxin; Diltiazem; Drug Interactions; Drug Therapy, Combination; Female; Heart Diseases; Humans; Kidney; Kidney Diseases; Kinetics; Liver Diseases; Male; Middle Aged; Nifedipine; Radioimmunoassay; Verapamil | 1985 |
17 other study(ies) available for diltiazem and Kidney Diseases
| Article | Year |
|---|---|
Protective effect of selected calcium channel blockers and prednisolone, a phospholipase-A2 inhibitor, against gentamicin and carbon tetrachloride-induced nephrotoxicity.
Topics: Animals; Antioxidants; Biomarkers; Calcium Channel Blockers; Carbon Tetrachloride; Cytoprotection; Diltiazem; Disease Models, Animal; Gentamicins; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Nifedipine; Oxidative Stress; Phospholipase A2 Inhibitors; Prednisolone; Rats, Wistar; Time Factors; Verapamil | 2014 |
[Case of reversible posterior leukoencephalopathy syndrome after discontinuation of antihypertensive therapy].
Topics: Adult; Antihypertensive Agents; Brain Edema; Chronic Disease; Diltiazem; Humans; Hypertension; Kidney Diseases; Leukoencephalopathies; Magnetic Resonance Imaging; Male; Patient Compliance; Severity of Illness Index; Treatment Outcome | 2010 |
Role of diltiazem in pregnant women with chronic renal disease.
Topics: Adult; Blood Pressure; Calcium Channel Blockers; Case-Control Studies; Chronic Disease; Diltiazem; Female; Fetal Growth Retardation; Humans; Kidney Diseases; Labor, Induced; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Proteinuria; Retrospective Studies | 2002 |
[Prevention of diltiazem in tacrolimus-induced nephrotoxicity: experiment with rats].
Topics: Animals; Creatine; Cyclosporine; Diltiazem; Disease Models, Animal; Dose-Response Relationship, Drug; Kidney; Kidney Diseases; Kidney Transplantation; Male; Postoperative Period; Random Allocation; Rats; Rats, Sprague-Dawley; Tacrolimus | 2007 |
A comparison of the effect of feeding a low-protein diet and of pharmacological intervention on the course of ablation nephropathy in the rat.
Topics: Analysis of Variance; Animals; Body Weight; Diet, Protein-Restricted; Diltiazem; Disease Models, Animal; Drug Evaluation, Preclinical; Enalapril; Kidney Diseases; Male; Nephrectomy; Rats; Rats, Wistar; Time Factors | 1995 |
[Basic studies on the prevention of cyclosporin A induced nephrotoxicity].
Topics: Animals; Cyclosporine; Diltiazem; Humans; Kidney; Kidney Diseases; Lymphocyte Activation; Male; Rats; Rats, Wistar; Theophylline | 1994 |
Comparative modulating effects of captopril, diltiazem, dietary calcium and pyridoxal-5'-phosphate on gentamicin-induced nephrotoxicity in the rat.
Topics: Animals; Body Weight; Calcium, Dietary; Captopril; Diltiazem; Female; Gentamicins; Glutathione; Injections, Intramuscular; Kidney Cortex; Kidney Diseases; Kidney Function Tests; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley | 1993 |
Effect of diltiazem and methyldopa on gestation-related renal complications in rats with adriamycin nephrosis. Relationship to glomerular prostanoid synthesis.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Diltiazem; Doxorubicin; Female; Hypertension; Kidney Diseases; Kidney Glomerulus; Methyldopa; Pregnancy; Pregnancy Complications; Prostaglandins; Proteinuria; Rats; Rats, Wistar | 1995 |
Pharmacological studies on a new antihypertensive agent, S-2150, a benzothiazepine derivative: 2. Hypotensive effects in normotensive and hypertensive rats.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Calcium Channels; Cardiovascular Diseases; Diltiazem; Heart Rate; Hypertension; Hypotension; Kidney Diseases; Male; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR; Rats, Wistar | 1996 |
Is there a beneficial effect of the calcium channel blocker diltiazem on cyclosporine A nephrotoxicity in rats?
Topics: Animals; Body Weight; Calcium Channel Blockers; Cyclosporine; Cytochrome P-450 Enzyme System; Diltiazem; Drug Interactions; Ethylmorphine; Female; Glomerular Filtration Rate; Glutathione; Immunosuppressive Agents; Kidney; Kidney Diseases; Liver; Organ Size; p-Aminohippuric Acid; Rats; Rats, Wistar | 1998 |
Nifedipine, verapamil and diltiazem block shock-wave-induced rises in cytosolic calcium in MDCK cells.
Topics: Adenosine Triphosphate; Animals; Aspartate Aminotransferases; Bradykinin; Calcium; Calcium Channel Blockers; Cell Line; Cytosol; Diltiazem; Dogs; Enzyme Inhibitors; Fluorescent Dyes; Fura-2; Kidney Diseases; Kidney Tubules; L-Lactate Dehydrogenase; Lithotripsy; Nifedipine; Thapsigargin; Verapamil | 1998 |
Role of diltiazem on tacrolimus pharmacokinetics in tacrolimus-induced nephrotoxic rats.
Topics: Animals; Calcium Channel Blockers; Diltiazem; Immunosuppressive Agents; Kidney; Kidney Cortex; Kidney Diseases; Kidney Function Tests; Kidney Medulla; Male; Rats; Rats, Sprague-Dawley; Tacrolimus; Tissue Distribution | 1999 |
Mechanism of FK506-induced renal hypoperfusion and its reversion in rats.
Topics: Animals; Calcium Channel Blockers; Diltiazem; Drug Interactions; Endothelins; Glomerular Filtration Rate; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; Perfusion; Rats; Rats, Sprague-Dawley; Tacrolimus; Urination | 2001 |
Radiographic contrast media induced nephropathy: experimental observations and the protective effect of calcium channel blockers.
Topics: Animals; Calcium Channel Blockers; Chromium; Contrast Media; Diatrizoate; Diltiazem; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epoprostenol; Indomethacin; Injections, Intraperitoneal; Iohexol; Kidney Diseases; Male; Models, Animal; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley | 2001 |
Glomerular hyperfiltration, intrarenal hemodynamics, and chronic allograft nephropathy: physiopathology of chronic allograft nephropathy.
Topics: Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Chronic Disease; Diltiazem; Follow-Up Studies; Glomerular Filtration Rate; Hemodynamics; Humans; Kidney Diseases; Kidney Transplantation; Renal Circulation; Transplantation, Homologous | 2002 |
Amelioration of experimental cyclosporine nephrotoxicity by calcium channel inhibition.
Topics: Animals; Calcium Channel Blockers; Cyclosporine; Diltiazem; Glomerular Filtration Rate; Kidney; Kidney Diseases; Male; Rats; Rats, Sprague-Dawley; Renal Circulation; Thromboxane B2 | 1992 |
Mechanisms of cyclosporine A toxicity in defined cultures of renal tubule epithelia: a role for cysteine proteases.
Topics: Animals; Calcium; Cell Death; Cells, Cultured; Cyclosporine; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Diltiazem; Dose-Response Relationship, Drug; Epithelial Cells; Epithelium; Humans; Kidney Diseases; Kidney Tubules; Leucine; Microscopy, Fluorescence; Nifedipine; Rabbits; Time Factors; Verapamil | 1991 |